´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Á¦17Â÷ Çмú´ëȸ(2ÀÏÂ÷) : 2022-06-10±³À°ÀÏÀÚ : 2022-06-10
±³À°Àå¼Ò : (¿ÀÇÁ¶óÀÎ) ¼¿ï µå·¡°ï½ÃƼ
±³À°ÁÖÁ¦ :
´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Á¦17Â÷ Çмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Áø´ÜÀ¯ÀüÇÐȸ
´ã´çÀÚ : Á¤¹Ì¼±
¿¬¶ôó : 02-772-9004
À̸ÞÀÏ :
ksgd.office@gmail.com ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 09:00~09:30 Precision Medicine Approaches in Cardiovascular Disease using NGS: Monogenic, Polygenic and Somatic Variant ¼ÛÇÑ(Áö³ð¿ÀÇǴϾð/Æ®À§½ºÆ®¹ÙÀÌ¿À»çÀ̾ð½º)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 09:30~10:00 Agilent NGS Automation Sample Prep Solution ¾çÁö¿ø(Çѱ¹¾ÖÁú·±Æ®)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 10:00~10:30 Clinical Utility of NGS Based ctDNA Testing ÀÌÁö¼ö(¼¿ïÀÇ´ë/Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 11:00~11:30 Implementation of AVENIO ctDNA Expanded Kit in the Clinical Laboratory ¼¼öÇö(¼¿ïÀÇ´ë/Çѱ¹·Î½´Áø´Ü)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 11:30~12:00 Circulating Tumor DNA Liquid Biopsy as a Tool for Precision Oncology ±è¼ö¿¬(¾ÆÀÌ¿¥ºñµð¿¢½º)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 12:00~13:00 Experiences from Ion Torrent Genexus ±èÁ¾¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 12:00~13:00 Improved Diagnosis of Various Inborn Errors: Beyond Gene Panel ±è¸í½Å(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 13:00~13:30 ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ±â¹ÝÀÇ Ç×»ýÁ¦ ³»¼º ¼¼±Õ Àå °¨¿° Ä¡·áÁ¦ °³¹ß À±»ó¼±(¿¬¼¼ÀÇ´ë ¹Ì»ý¹°Çб³½Ç)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 13:30~14:00 Exploring Human Skin Microbiome: Fundamentals, Pitfalls and Potential Application for Skin Disease ¹ÚÁø(ÀüºÏÀÇ´ë ÇǺΰúÇб³½Ç)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 14:00~14:30 ÀÓ»ó°úÀÇ Çù·Â ¿¬±¸¸¦ ÅëÇÑ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È °ü·Ã ¿¬±¸ °æÇè ¼Ò°³ ¿øÀºÁ¤(Àü³²ÀÇ´ë ±â»ýÃæÇб³½Ç)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 13:00~13:30 Ç÷¾× À¯Àü°Ë»ç °á°ú º¸°í ¹× ¼³¸í ½Å»õ¾Ï(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 13:30~14:00 Á¾¾ç À¯Àü°Ë»ç °á°ú º¸°í ¹× ¼³¸í ±èµµÈÆ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 14:00~14:30 ¾à¹° À¯Àü°Ë»ç °á°ú º¸°í ¹× ¼³¸í ÀÓÁ¤ÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 15:00~15:30 Non-Small Cell Lung Cancer: Experience of ctDNA Testing in a Clinical Laboratory ÀÌ¿ìâ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 15:30~16:00 Clinical Utility of ctDNA Testing in Prostate Cancer ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë ºñ´¢ÀÇÇаú)
±³À°½Ã°£ 06-10 ¼¼¼ÇA(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó1Ȧ) 16:00~16:30 Application of ctDNA in the Diagnosis and Monitoring of Esophageal Cancer ¹Ú¼º¿ë(¼º±Õ°üÀÇ´ë ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 15:00~15:30 À¯Àü »ó´ã ±¹³» ÇöȲ ±èÁöÀº(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 15:30~16:00 À¯Àü »ó´ã ±¹¿Ü ÇöȲ ±è¾Æ¶û(ÀÌÈ¿©ÀÚ´ëÇб³ À¯Àü»ó´ã´ëÇпø)
±³À°½Ã°£ 06-10 ¼¼¼ÇB(¼¿ïµå·¡°ï½ÃƼ 3F ÇѶó3Ȧ) 16:00~16:30 À¯Àü »ó´ã °ü·Ã À±¸®Àû/»çȸÀû À̽´ ·ùÇö¹Ì(Â÷ÀÇ´ë »êºÎÀΰú)